Latest News and Press Releases

Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified event threshold of 80% overall survival (OS) events was...

Washington D.C., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization dedicated to ending colorectal cancer, will begin its fifth...

Data presented at 16th World ADC London Summit with lead programme in colorectal cancer highlight the promise of Promatix’s proteomics-based platform to optimise cis-bispecific antibody-drug conjugate...

Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes ...

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology Market, till 2040: Distribution by Type of Cancer, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts"...

OSLO, Norway, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Augere Medical (“Augere”), a European pioneer in AI-assisted colonoscopy, today announced the commercial release of its next-generation software...

Springfield, Mo., Jan. 22, 2026 (GLOBE NEWSWIRE) -- New research from the American Cancer Society (ACS), published today in the Journal of the American Medical Association (JAMA), confirms a grim...

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal...

Larkspur Biosciences announced the first participant has been dosed in the Phase 1 clinical study of its lead candidate, LRK-4189, in healthy volunteers.